Diagnostic and therapeutic options in the managment of nonvariceal upper gastrointestinal bleeding

Current Gastroenterology Reports

Volumn 5, Issue 6, 2003, Pages 476-481

  Pais, Shireen Andrade ^a   Yang, Russell ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FAMOTIDINE; FIBRIN GLUE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; POLIDOCANOL; PROTON PUMP INHIBITOR; RABEPRAZOLE; SCLEROSING AGENT; THROMBIN; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; SULFOXIDE;

ANAPHYLAXIS; ARGON PLASMA COAGULATION; BLOOD CLOTTING DISORDER; CLINICAL EXAMINATION; CLINICAL TRIAL; CLIP; COST EFFECTIVENESS ANALYSIS; DRUG MEGADOSE; EMBOLISM; ENDOSCOPIC THERAPY; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT MONITORING; PEPTIC ULCER BLEEDING; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SIDE EFFECT; THERMOCOAGULATION; THROMBOSIS; UPPER GASTROINTESTINAL BLEEDING; VIRUS TRANSMISSION; DIATHERMY; ECONOMICS; GASTROINTESTINAL HEMORRHAGE; PATHOPHYSIOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DIATHERMY; ENDOSCOPY, GASTROINTESTINAL; FIBRIN TISSUE ADHESIVE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMANS; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; PROGNOSIS; RISK ASSESSMENT; SULFOXIDES;

EID: 1542435302     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0036-4     Document Type: Review

References (47)

1. Longstreth GF: Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population based study. Am J Gastroenterol 1995, 90:206-210.
2. Rockall TA, Logan RFA, Devlin HB, et al.: Incidence of and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. BMJ 1995, 311:222-226.
3. Rockall TA, Logan RFA, Devlin HB, et al.: Risk assessment after acute upper gastrointestinal hemorrhage. Gut 1996, 38:316-321.
4. Vreeburg EM, Terwee CB, Snel P et al.: Validation of Rockall risk scoring system in upper gastrointestinal bleeding. Gut 1999, 44:331-335.
5. Sanders DS, Carter MJ, Goodchap RJ, et al.: Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol 2002, 92:630-635.
6. Cipolletta L, Bianco MA, Rotondano G, et al.: Outpatient management of nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 2002, 55:1-5.
7. Oei TT, Dulai GS, Gralnek IM, et al.: Hospital care for low-risk patients with acute, nonvariceal upper GI hemorrhage: a comparison of neighboring community and tertiary care centers. Am J Gastroenterol 2002, 97:2271-2278.
8. Spiegel BR, Vakil NB, Ofman JJ, et al.: Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: Is sooner better? Arch Intern Med 2001, 61:1393-1404.
9. Cooper GS, Chak A, Hammar PJ: The effectiveness of endoscopy in patients with upper gastrointestinal hemorrhage: a community based study. Gastrointest Endosc 1999, 49:145-152.
10. Laine L, Peterson WL: Bleeding peptic ulcer. N Engl J Med 1994, 331:717-727.
11. Rockey DC: Gastrointestinal bleeding. In Sleisenger and Fordtran's Gastrointestinal and Liver Diseases. Edited by Feldman M, Friedman LS, Sleisenger MH. Philadelphia: WB Saunders; 2002:218-219.
12. Proceedings from the consensus conference on therapeutic endoscopy in bleeding ulcers, March 6-8, 1989. Gastrointest Endosc 1990, 36:S1-S65.
13. Laine L, Freeman M, Cohen H: Lack of uniformity in diagnosis of endoscopic prognostic features of bleeding ulcers. Gastrointest Endosc 1994, 40:411-417.
14. Lau JYW, Sung JJY, Chan ACW, et al.: Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endosc 1997, 46:33-36.
15. Gralnek IM, Jensen DM, Kovacs TOG, et al.: An economic analysis of patients with active arterial peptic ulcer hemorrhage treated with endoscopic heater probe, injection sclerosis, or surgery in a prospective, randomized trial. Gastrointest Endosc 1997, 46:105-117.
16. Gralnek IM, Jensen DM, Gornbein J, et al.: Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and non-bleeding visible vessel: an analysis of two prospective clinical trials. Am J Gastroenterol 1998, 93:2047-2057.
17. Lee JG, Turnipseed S, Romano PS, et al.: Endoscopy based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized control trial. Gastrointest Endosc 1999, 50:755-761.
18. Dulai GS, Gralnek IM, Oei TT, et al.: Utilization of healthcare resources for low-risk patients with acute, non-variceal upper GI hemorrhage (UGIH): a retrospective cohort study. Gastrointest Endosc 2002, 55:321-327.
19. Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992, 102:139-148.
20. Laine L, Stein C, Sharma V: A prospective outcome of patients with clot in an ulcer and the effect of irrigation. Gastrointest Endosc 1996, 43:107-110.
21. Bleau BL, Gostout CJ, Shaw MJ, et al.: Final results: rebleeding from peptic ulcers associated with adherent clots: a prospective randomized controlled study comparing endoscopic therapy with medical therapy [abstract]. Gastrointest Endosc 1997, 45:AB87.
22. Jensen DM, Kovacs TOG, Jutabha R, et al.: Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002, 123:407-413.
23. Chung SC, Lau JYW, Sung JY, et al.: Randomized comparison between adrenaline injection alone and adrenaline injection plus heater probe treatment for actively bleeding ulcers. BMJ 1997, 314:1307-1311.
24. Lin HJ, Tseng GY, Perng CL, et al.: Comparision of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut 1999, 44:715-719.
25. Lin HJ, Perng CL, Lee SD, et al.: Is sclerosant mandatory after an epinephrine injection for the arrest of peptic ulcer hemorrhage? A prospective, randomized, comparative study. Gut 1993, 34:1182-1185.
26. Juszkiewicz P, Wajda Z, Dobosz M, et al.: The role of endoscopic thrombin injections in the treatment of gastroduodenal bleeding. S Afr J Surg 1993, 31:98-102.
27. Kubba A, Murphy W, Palmer KR: Endoscopic injection for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus human thrombin. Gastroenterology 1996, 111:623-628.
28. Rutgeerts P, Rauws E, Wara P, et al.: Randomized trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet 1997, 350:692-696.
29. Cipolletta L, Bianco MA, Marmo R, et al.: Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 2001, 53:147-151.
30. Buffoli F, Graffeo M, Nicosia F, et al.: Peptic ulcer bleeding: a comparison of two hemostatic procedures. Am J Gastroenterol 2001, 91:89-94.
31. Gevers AM, de Goede E, Simoens M, et al.: A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers. Gastrointest Endosc 2002, 55:466-469.
32. Lin HJ, Hsieh YH, Tseng GY, et al.: A prospective, randomized trial of endoscopic hemoclip versus heater probe thermocoagulation for peptic ulcer bleeding. Am J Gastroenterol 2002, 97:2250-2254.
33. Cipolletta L, Bianco MA, Rotondano G, et al.: Prospective comparison of argon plasma coagulator and heater probe in the endoscopic treatment of major peptic ulcer bleeding. Gastrointest Endosc 1998, 48:191-195.
34. Chau CH, Sieu WT, Law BKB, et al.: Randomized controlled trial comparing adrenaline injection plus heat probe versus adrenaline injection plus argon plasma coagulation for bleeding peptic ulcers. Gastrointest Endosc 2003, 57:455-461.
35. Marmo R, Rotondano G, Bianco MA, et al.: Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc 2003, 57:62-67.
36. Messman H, Schaller P, Andus T, et al.: Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric and duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy 1998, 30:583-589.
37. Wong SKH, Yu LM, Lau JYW, et al.: Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002, 50:322-325.
38. Saeed ZA, Cole RA, Ramirez FC, et al.: Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial. Endoscopy 1996, 28:288-294.
39. Lau, JY, Sung JJ, Lam YH, et al.: Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999, 340:751-756.
40. Khuroo MS, Yattoo GN, Javid G, et al.: A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997, 336:1054-1058.
41. Javid G, Masoodi I, Zargar SA, et al.: Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001, 111:280-284.
42. Blum RA, Hung RH, Kidd SL, et al.: Dose-response relationship of lansoprazole to gastric acid antisecretory effects. Aliment Pharmacol Ther 1998, 12:321-327.
43. Lau JYW, Sung JJY, Lee KKC, et al.: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000, 343:310-316.
44. Sung JJ, Chan FK, Lau JY, et al.: Intravenous proton pump inhibitor alone or in combination with endoscopic therapy for peptic ulcer with adherent clot or protuberant vessel [abstract]. Gastroenterology 2003, 124(Suppl 1):A16.
45. Saunders S, Jensen D, Pace S, et al.: Lower rebleeding rates than expected in an ongoing study comparing intravenous pantoprazole to ranitidine to prevent peptic ulcer rebleeding [abstract]. Gastroenterology 2003, 124(Suppl 1):A627.
46. Taubel JJ, Sharma VK, Chiu YL, et al.: A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-hour intragastric pH. Aliment Pharmacol Ther 2001, 15:1807-1817.
47. Kuwayama H, Takano Y, Kameina T, et al.: Effect of oral rabeprazole on gastric pH during anesthesia induction and during general anesthesia [abstract]. Gastroenterology 2001, 120(Suppl 1):A729.